LCD-L39948
Document details
Summary
The introduction of this LCD could impact billing practices for genetic testing related to hereditary transthyretin amyloidosis. Providers may need to familiarize themselves with the specific criteriaNew LCD for hereditary transthyretin amyloidosis testing.
Affected codes
ICD-10-CM
Affected specialty
Genetic Testing alerts →Source document
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39948&ver=7CLV Intelligence summarizes publicly available federal publications. Not affiliated with or endorsed by any government agency.
Related alerts
4Policy LCD-DL40238 · Hematology
The proposed LCD on genetic testing for hereditary thrombophilia could influence billing practices related to genetic testing claims. Providers may need to ensure compliance with the new guidelines to
View alertPolicy LCD-DL40259 · Hematology
The proposed Local Coverage Determination (LCD) for genetic testing related to hereditary thrombophilia could significantly impact claims processing and reimbursement rates for genetic tests in this a
View alertPolicy LCD-DL40242 · Hematology
The proposed Local Coverage Determination (LCD) for genetic testing related to hereditary thrombophilia requires billing team review
View alertPolicy LCD-DL40274 · Hematology
The proposed LCD on genetic testing for hereditary thrombophilia could lead to enhanced coverage for specific tests, impacting the way providers bill for related services. This may increase the number
View alert